For-Robin, Inc.

As President and CSO I am happy to share that For-Robin was incorporated 10 years ago today!
https://for-robin.com/

The National Cancer Institute's NExT program partnership has done 3rd party validation of hJAA-F11's tumor targeting ability, and with Thermo Fisher, a master cell bank is producing our antibody, with BDP the cGMP cell line is being prepared, the excellent stability of our antibody has been shown , with NExT and Roswell Park Comprehensive Cancer Center we are preparing for the FDA IND, and our imaging clinical trial!

Thank you to Thermo-Fisher, NExT, Roswell Park Comprehensive Cancer Institute, the University at Buffalo, and especially Dr. Grace Dy, Dr James Olson (Vice President, Toxicologist) Dr Sally Quataert (CEO)!

For- Robin: A Company with a Mission News: Patented in US, Europe, Japan, Australia, Russia & China. NCI NExT : Milestone completed: tumor specificity validated.

European patent granted!